Evidence map›Paper›PMID 41671378›Full record

ArticleScience advances2026

Silencer variants are key drivers of gene up-regulation in Alzheimer's disease.

Di Huang, Ivan Ovcharenko

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Context-dependent regulatory variants in Alzheimer's disease.bioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Di HuangDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0009-0002-2992-3135
Ivan OvcharenkoDivision of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-9730-7732

Funding

Regulatory landscape of the human genome: comparative and evolutionary analysis.Z01LM200881 · NLM · NATIONAL LIBRARY OF MEDICINE · PI OVCHARENKO, IVAN · 2008 to 2008
$690k
Intramural NIH HHS Z01 LM200881
6 · The paper itself

Abstract

The genetic mechanisms of ~90% of Alzheimer's disease (AD)-associated variants residing in noncoding DNA remain poorly understood. To address this, we developed a deep learning framework that integrates bulk histone modification data with single-cell open chromatin profiles to evaluate the regulatory potential of noncoding variants. This model identified 1457 silencer and 3084 enhancer AD-associated variants in dorsolateral prefrontal cortex, classifying gene loci as silencer-only (SL), enhancer-only (EN), or dual-function (ENSL). EN loci predominantly regulate housekeeping metabolic processes, SL loci (including

Indexed as

Alzheimer DiseaseSilencer Elements, TranscriptionalUp-RegulationEnhancer Elements, GeneticGenetic Predisposition to DiseaseHumansPolymorphism, Single Nucleotide

Identifiers

PMID41671378
PMCPMC12893287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.